{"id":27550,"date":"2024-01-12T19:26:05","date_gmt":"2024-01-13T00:26:05","guid":{"rendered":"https:\/\/www.ipoboutique.com\/blog\/?p=27550"},"modified":"2024-01-12T19:26:05","modified_gmt":"2024-01-13T00:26:05","slug":"pipeline-update-biotech-filings-highlight-week-of-1-12-24","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/pipeline-update-biotech-filings-highlight-week-of-1-12-24\/","title":{"rendered":"Pipeline Update: Biotech filings highlight week of 1\/12\/24"},"content":{"rendered":"

Terms Added<\/span><\/u><\/b><\/p>\n

\u00a0<\/u><\/b><\/span><\/div>\n
\n

Company: Palmer Square Capital BDC Inc.<\/p>\n

Symbol: PSBD<\/p>\n

Description: Palmer Square is an externally managed, non-diversified closed-end management investment company that primarily lends to and invests in corporate debt securities, including small to large private U.S. companies, and has elected to be regulated as a business development company under the Investment Company Act of 1940.<\/p>\n

Shares: 5.45 million<\/p>\n

Price Range: $16.45-$16.45<\/p>\n

Market Cap: $535m-$535m<\/p>\n

Trade Date:\u00a0 Thursday, 1\/18<\/p>\n

Underwriters: J.P. Morgan, BofA Securities, RBC Capital, UBS Investment Bank, Citigroup<\/p>\n

Co-Manager(s): Janney Montgomery, Scott, Oppenheimer, Clear Street<\/p>\n

Link to Prospectus: Terms Added: 1-8-24<\/a><\/p>\n


<\/p>\n

\u00a0<\/span><\/u><\/b><\/div>\n
New Filings (updated prospectuses)<\/span><\/u><\/b><\/div>\n
\u00a0<\/span><\/u><\/b><\/div>\n
\n

Company: Alto Neuroscience, Inc.<\/p>\n

Symbol: ANRO (NYSE)<\/p>\n

Description: They are a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options.<\/p>\n

Shares: TBD<\/p>\n

Price Range: TBD<\/p>\n

Trade Date:\u00a0 TBD<\/p>\n

Underwriters: Jefferies, TD Cowen, Stifel, William Blair<\/p>\n

Co-Manager(s): Baird<\/p>\n

Link to Prospectus: Filed: 1-12-24<\/a><\/p>\n

<\/p>\n

Company: Invea Therapeutics, Inc.<\/p>\n

Symbol: INAI (Nasdaq)<\/p>\n

Description: They are a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs.<\/p>\n

Shares: TBD<\/p>\n

Price Range: TBD<\/p>\n

Trade Date:\u00a0 TBD<\/p>\n

Underwriters: BofA Securities, Citigroup, Truist Securities<\/p>\n

Co-Manager(s): ThinkEquity<\/p>\n

Link to Prospectus: Updated Prospectus: 1-12-24<\/a><\/p>\n

<\/p>\n

\u2018<\/p>\n

Company: \u00a0Auna S.A.A.<\/p>\n

Symbol: AUNA<\/p>\n

Description:\u00a0 They operate hospitals and clinics in Mexico, Peru and Colombia, provide prepaid healthcare plans in Peru and provide dental and vision plans in Mexico.<\/p>\n

Shares: TBD<\/p>\n

Price Range: TBD<\/p>\n

Trade Date:\u00a0 TBD<\/p>\n

Underwriter(s): Morgan Stanley, JP Morgan, BTG Pactual, Santander, Citigroup, HSBC<\/p>\n

Link to Prospectus: Filed: 1-9-24<\/a><\/p>\n

<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":null,"zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":null,"zakra_breadcrumbs_separator_color":null,"zakra_breadcrumbs_link_color":null,"zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1536],"tags":[],"class_list":["post-27550","post","type-post","status-publish","format-standard","hentry","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/27550","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=27550"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/27550\/revisions"}],"predecessor-version":[{"id":27551,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/27550\/revisions\/27551"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=27550"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=27550"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=27550"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}